hotspot -WSS

hotspot

author：explore 2025-09-05 06:07:02 - browse：2

An artist's rendering of the building — currently under construction along Boston's Fort Point Channel — where Eli Lilly plans to open its Institute for Genetic Medicine. Courtesy Alexandria Real Estate Equities Inc

Eli Lilly and Co., which transformed itself from a stodgy underperformer into one of the world’s hottest pharmaceutical companies, said this week that the genetic medicine research center it plans to open in Boston in August will eventually employ twice as many workers as originally estimated.

In February 2022, Lilly said that it would increase its modest Massachusetts workforce from 120 to 250 employees when it opened the $700 million Lilly Institute for Genetic Medicine along Fort Point Channel. The Indianapolis-based company said it would move 120 scientists from Kendall Square in Cambridge to the institute and add another 130.

But Daniel Skovronsky, Lilly’s chief scientific and medical officer, said in an interview that the 12-story, 334,000-square-foot laboratory and office building will ultimately accommodate 500 Lilly scientists and researchers.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Anesthesiologist group: stop taking Ozempic before surgery
Next article： Readout Newsletter: Blackstone Life Sciences, Merck, Bluebird Bio

focus

hotspot

WSS

Readout Newsletter: Blackstone Life Sciences, Merck, Bluebird Bio

There's no autism epidemic. It's an autism diagnosis epidemic

STAT Summit: Ending the crisis of Black deaths in the U.S.

Covid vaccine financial winners and losers, from Pfizer to Novavax

Roche acquires Telavant from Roivant, adding experimental IBD treatment

How AI can help patients find reliable information about doctors

hotspot

hotspot

hotspot

BioMarin wins approval for gene therapy to treat hemophilia A

STAT Readout Newsletter: Biotech news today

Walensky prepares to leave CDC — and Congress — behind

Food as medicine: Medically tailored meals may get standardized

Medical leaders decry Supreme Court decision on affirmative action

Roche drug slashes death risk in early

In Memoriam: Notable people who died in 2023

Abortion pill case raises question: who can sue the FDA?

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Donor acceptance rates hint at racial, gender bias in heart transplants: study

hotspot

STAT Summit: Meghan O’Rourke on making chronic illness visible

Cassava Sciences’ Alzheimer’s clinical trials should be halted

The future of Biogen: Pragmatism, ‘moonshots,’ and no Twinkies

Vertex Pharmaceuticals may move headquarters in Boston

Health tech investors get more selective as pandemic boom fades

Roche acquires Telavant from Roivant, adding experimental IBD treatment

focus

focus

hotspot

focus